Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Cervical Cancer

  Free Subscription


1 AIDS Res Hum Retroviruses
1 Angiogenesis
2 Annu Int Conf IEEE Eng Med Biol Soc
2 Arch Gynecol Obstet
1 BMC Complement Med Ther
1 BMC Med Genomics
1 BMJ Open
1 Cancer Causes Control
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Sci
1 Cancers (Basel)
1 Chem Biol Interact
1 Dis Markers
1 Front Genet
2 Front Immunol
1 Front Med (Lausanne)
1 Front Oncol
2 Gynecol Oncol
1 Hum Vaccin Immunother
2 In Vivo
2 Int J Cancer
2 Int J Environ Res Public Health
2 Int J Gynecol Cancer
1 Int Urogynecol J
1 J Clin Oncol
1 J Infect
1 J Magn Reson Imaging
2 J Med Virol
1 J Natl Cancer Inst
1 Lasers Surg Med
2 Medicine (Baltimore)
1 Neurol Med Chir (Tokyo)
1 Oncol Rep
1 Pathol Res Pract
3 PLoS One
1 Pol J Radiol
1 Rev Invest Clin
1 Taiwan J Obstet Gynecol
1 Transl Cancer Res
1 Vaccine
1 Virol J
1 Zhong Nan Da Xue Xue Bao Yi Xue Ban

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AIDS Res Hum Retroviruses

  1. SCHINDLER S, Magalhaes RA, Costa ELF, Brites C, et al
    Genital cytokines in HIV/ human papillomavirus co-infection: a systematic review.
    AIDS Res Hum Retroviruses. 2022 Apr 18. doi: 10.1089/AID.2021.0139.
    PubMed         Abstract available


  2. CHEN XJ, Wei WF, Wang ZC, Wang N, et al
    Correction: A novel lymphatic pattern promotes metastasis of cervical cancer in a hypoxic tumour-associated macrophage-dependent manner.
    Angiogenesis. 2022 Sep 10. pii: 10.1007/s10456-022-09854.

    Annu Int Conf IEEE Eng Med Biol Soc

  3. ZHAO M, Ling M, Wang Z, Shi J, et al
    Whole Slide Image Multi-Classification of Cervical Epithelial Lesions Based on Unsupervised Pre-training.
    Annu Int Conf IEEE Eng Med Biol Soc. 2022;2022:594-598.
    PubMed         Abstract available

  4. KUPAS D, Harangi B
    Classification of Pap-smear cell images using deep convolutional neural network accelerated by hand-crafted features.
    Annu Int Conf IEEE Eng Med Biol Soc. 2022;2022:1452-1455.
    PubMed         Abstract available

    Arch Gynecol Obstet

  5. CORONADO PJ, Gonzalez-Granados C, Ramirez-Mena M, Calvo J, et al
    Development and psychometric properties of the human papillomavirus-quality of life (HPV-QoL) questionnaire to assess the impact of HPV on women health-related-quality-of-life.
    Arch Gynecol Obstet. 2022;306:1085-1100.
    PubMed         Abstract available

  6. LIU Y, Liao J, Yi X, Pan Z, et al
    Diagnostic value of colposcopy in patients with cytology-negative and HR-HPV-positive cervical lesions.
    Arch Gynecol Obstet. 2022;306:1161-1169.
    PubMed         Abstract available

    BMC Complement Med Ther

  7. KUMAR S, Mulchandani V, Das Sarma J
    Methanolic neem (Azadirachta indica) stem bark extract induces cell cycle arrest, apoptosis and inhibits the migration of cervical cancer cells in vitro.
    BMC Complement Med Ther. 2022;22:239.
    PubMed         Abstract available

    BMC Med Genomics

  8. ZOU S, Ye M, Zhang JA, Ji H, et al
    Establishment and genetically characterization of patient-derived xenograft models of cervical cancer.
    BMC Med Genomics. 2022;15:191.
    PubMed         Abstract available

    BMJ Open

  9. BAETEN IGT, Hoogendam JP, Braat AJAT, Veldhuis WB, et al
    Fluorescent Indocyanine Green versus Technetium-99m and Blue Dye for Bilateral SENTinel Lymph Node Detection in Stage I-IIA Cervical Cancer (FluoreSENT): protocol for a non-inferiority study.
    BMJ Open. 2022;12:e061829.
    PubMed         Abstract available

    Cancer Causes Control

  10. HERRIGES MJ, Pinkhasov R, Lehavot K, Shapiro O, et al
    The association of sexual orientation with prostate, breast, and cervical cancer screening and diagnosis.
    Cancer Causes Control. 2022 Sep 9. pii: 10.1007/s10552-022-01624.
    PubMed         Abstract available

    Cancer Epidemiol Biomarkers Prev

  11. AITKEN CA, Inturrisi F, Kaljouw S, Nieboer D, et al
    Sociodemographic characteristics and screening outcomes of women preferring self-sampling in the Dutch cervical cancer screening programme: a population-based study.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 13. pii: 709191.
    PubMed         Abstract available

    Cancer Sci

  12. KUDO R, Sekine M, Yamaguchi M, Hara M, et al
    Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity.
    Cancer Sci. 2022;113:3211-3220.
    PubMed         Abstract available

    Cancers (Basel)

  13. SAHA S, Rundle S, Kotsopoulos IC, Begbie J, et al
    Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy.
    Cancers (Basel). 2022;14.
    PubMed         Abstract available

    Chem Biol Interact

  14. WU PJ, Hsin IL, Hung WL, Lee MS, et al
    Combination treatment with cyclosporin A and arsenic trioxide induce synergistic cell death via non-apoptotic pathway in uterine cervical cancer cells.
    Chem Biol Interact. 2022 Sep 10:110177. doi: 10.1016/j.cbi.2022.110177.
    PubMed         Abstract available

    Dis Markers

  15. FAN Y, Wang Y, Liu F, Wang H, et al
    SEC61G Promotes Cervical Cancer Proliferation by Activating MAPK Signaling Pathway.
    Dis Markers. 2022;2022:7016079.
    PubMed         Abstract available

    Front Genet

  16. LEI L, Tan L, Sui L
    A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer.
    Front Genet. 2022;13:957744.
    PubMed         Abstract available

    Front Immunol

  17. JI H, Zhang JA, Liu H, Li K, et al
    Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
    Front Immunol. 2022;13:976107.
    PubMed         Abstract available

  18. XU F, Zou C, Gao Y, Shen J, et al
    Comprehensive analyses identify RIPOR2 as a genomic instability-associated immune prognostic biomarker in cervical cancer.
    Front Immunol. 2022;13:930488.
    PubMed         Abstract available

    Front Med (Lausanne)

  19. CORREA FM, Migowski A, de Almeida LM, Soares MA, et al
    Cervical cancer screening, treatment and prophylaxis in Brazil: Current and future perspectives for cervical cancer elimination.
    Front Med (Lausanne). 2022;9:945621.
    PubMed         Abstract available

    Front Oncol

  20. WANG Q, He Y, Long F, Li C, et al
    Cervical cancer screening in high-altitude areas in China: A large cross-section study of 25,173 women in northern Tibet.
    Front Oncol. 2022;12:841547.
    PubMed         Abstract available

    Gynecol Oncol

  21. RASMUSSEN CL, Thomsen LT, Baandrup L, Franzmann MB, et al
    Changes in HPV prevalence in Danish women with vulvar cancer during 28 years - A nationwide study of >1300 cancer cases.
    Gynecol Oncol. 2022 Jun 21. pii: S0090-8258(22)00418.
    PubMed         Abstract available

  22. PUJADE-LAURAINE E, Tan DSP, Leary A, Mirza MR, et al
    Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review.
    Gynecol Oncol. 2022 Sep 9. pii: S0090-8258(22)00552.
    PubMed         Abstract available

    Hum Vaccin Immunother

  23. WONG LP, Alias H, Seheli FN, Zimet GD, et al
    Human papillomavirus (HPV) vaccination intent and its associated factors: a study of ethnically diverse married women aged 27 to 45 in Malaysia, a Southeast Asian country.
    Hum Vaccin Immunother. 2022;18:2076525.
    PubMed         Abstract available

    In Vivo

  24. CATTANEO CG, Musio D, Tanzi F, Guidi G, et al
    Synchronous Anal Canal Cancer and Cervical Cancer: Report of a Case and Management Implication.
    In Vivo. 2022;36:2521-2524.
    PubMed         Abstract available

  25. SALIH MM, Almehmadi M, Shafie A, Alsharif A, et al
    Evaluation of CD4+:CD8+ Ratio in Patients With Cervical Cancer and the Levels of Inflammatory Markers.
    In Vivo. 2022;36:2414-2421.
    PubMed         Abstract available

    Int J Cancer

  26. KAHESA C, Thomsen LT, Linde DS, Mchome B, et al
    Comparison of human papillomavirus (HPV)-based cervical cancer screening strategies in Tanzania among women with and without HIV.
    Int J Cancer. 2022 Sep 12. doi: 10.1002/ijc.34283.
    PubMed         Abstract available

  27. HAMPL M, Hesselink AT, Meijer CJLM, Denecke A, et al
    Evaluation of FAM19A4/miR124-2 methylation performance in the management of CIN3 diagnosed pregnant women.
    Int J Cancer. 2022 Jun 6. doi: 10.1002/ijc.34153.
    PubMed         Abstract available

    Int J Environ Res Public Health

  28. BAUTISTA-VALAREZO E, Crespo BV, Maldonado-Rengel R, Espinosa ME, et al
    Knowledge and Perceptions about Cervical Cancer and HPV Screening in Women in Rural Areas of Ecuador: A Qualitative Research Study.
    Int J Environ Res Public Health. 2022;19.
    PubMed         Abstract available

  29. VERRO B, Gallina S, Saraniti C
    Papillomavirus Infection and Prevention: How Much Does the Sicilian Population Know? An Observational Study.
    Int J Environ Res Public Health. 2022;19.
    PubMed         Abstract available

    Int J Gynecol Cancer

  30. CIBULA D, Borcinova M, Kocian R, Feltl D, et al
    CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16).
    Int J Gynecol Cancer. 2022 Sep 13. pii: ijgc-2022-003918.
    PubMed         Abstract available

  31. CIBULA D
    Early-stage intermediate-risk-the group with the most heterogenous management among patients with cervical cancer.
    Int J Gynecol Cancer. 2022 Sep 13. pii: ijgc-2022-003908.

    Int Urogynecol J

  32. HE R, Xue Y, Zhuang X, Wang H, et al
    Comparison of long-term bowel symptoms after laparoscopic radical hysterectomy versus abdominal radical hysterectomy in patients with cervical cancer.
    Int Urogynecol J. 2022 Sep 12. pii: 10.1007/s00192-022-05351.
    PubMed         Abstract available

    J Clin Oncol

  33. KREMER WW, Dick S, Heideman DAM, Steenbergen RDM, et al
    Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/miR124-2 DNA Methylation (CONCERVE Study).
    J Clin Oncol. 2022;40:3037-3046.
    PubMed         Abstract available

    J Infect

  34. XIA X, Shao D, Liu H, Huang M, et al
    Age-specific prevalence of high-risk human papillomavirus infection among women in rural China, 2016-2018.
    J Infect. 2022;85:e92-e93.

    J Magn Reson Imaging

  35. WANG W, Fan X, Yang J, Wang X, et al
    Preliminary MRI Study of Extracellular Volume Fraction for Identification of Lymphovascular Space Invasion of Cervical Cancer.
    J Magn Reson Imaging. 2022 Sep 12. doi: 10.1002/jmri.28423.
    PubMed         Abstract available

    J Med Virol

  36. DONG B, Huang Y, Cai H, Chen Y, et al
    Prevotella as the hub of the cervicovaginal microbiota affects the occurrence of persistent human papillomavirus infection and cervical lesions in women of childbearing age via host NF-kappaB/C-myc.
    J Med Virol. 2022;94:5519-5534.
    PubMed         Abstract available

  37. DEBERNARDI A, Valot B, Almarcha J, Guenat D, et al
    Longitudinal follow-up of HPV16 sequence after cervical infection: Low intrahost variation and no correlation with clinical evolution.
    J Med Virol. 2022;94:5512-5518.
    PubMed         Abstract available

    J Natl Cancer Inst

  38. HU SY, Kreimer AR, Porras C, Guillen D, et al
    Performance of cervical screening a decade following HPV vaccination: The Costa Rica Vaccine Trial.
    J Natl Cancer Inst. 2022 May 31. pii: 6596052. doi: 10.1093.
    PubMed         Abstract available

    J UOEH

  39. TOHYAMA A, Kurita T, Shibahara M, Harada H, et al
    Poorly Differentiated Cervical Squamous Cell Carcinoma Resembling Giant Cell Carcinoma of the Lung: Extreme Morphology of This Tumor and Its Clinical Course.
    J UOEH. 2022;44:263-267.
    PubMed         Abstract available

    Lasers Surg Med

  40. ZHANG Y, Su Y, Tang Y, Qin L, et al
    Management of patients with positive margin after conization for high-grade cervical intraepithelial lesions.
    Lasers Surg Med. 2022;54:1099-1106.
    PubMed         Abstract available

    Medicine (Baltimore)

  41. SUN H, Wang N, Wang X, Huang G, et al
    A study of different minimum segment area parameters on automatic IMRT plans for cervical cancer using Pinnacle3 9.10 TPS.
    Medicine (Baltimore). 2022;101:e29290.
    PubMed         Abstract available

  42. MAIMAITIMING N, Ma X, Wei Y, Cao L, et al
    Efficacy and safety of endostar combined with chemoradiotherapy versus chemoradiotherapy alone in locally advanced cervical cancer: A PRISMA-compliant systematic review and meta-analysis.
    Medicine (Baltimore). 2022;101:e30170.
    PubMed         Abstract available

    Neurol Med Chir (Tokyo)

  43. TSUJI Y, Fukuo Y, Kanemitsu T, Katayama Y, et al
    Multimodal Management of Combined Posterior and Anterior Surgical Approach and Postoperative Pharmacological Therapy for Giant Cell Tumor of the Cervical Spine Encasing the Vertebral Artery: A Technical Case Report.
    Neurol Med Chir (Tokyo). 2022 Aug 27. doi: 10.2176/jns-nmc.2022-0158.
    PubMed         Abstract available

    Oncol Rep

  44. XING F, Song Z, Cheng Z
    High expression of PDIA4 promotes malignant cell behavior and predicts reduced survival in cervical cancer.
    Oncol Rep. 2022;48.
    PubMed         Abstract available

    Pathol Res Pract

  45. ZENG R, Xiong X
    Effect of NMB-regulated ERK1/2 and p65 signaling pathway on proliferation and apoptosis of cervical cancer.
    Pathol Res Pract. 2022;238:154104.
    PubMed         Abstract available

    PLoS One

  46. GALESHI M, Shirafkan H, Yazdani S, Motaghi Z, et al
    Reproductive health needs of Human papillomavirus (HPV) positive women: A systematic review.
    PLoS One. 2022;17:e0266819.
    PubMed         Abstract available

  47. DERBIE A, Amare B, Misgan E, Nibret E, et al
    Histopathological profile of cervical punch biopsies and risk factors associated with high-grade cervical precancerous lesions and cancer in northwest Ethiopia.
    PLoS One. 2022;17:e0274466.
    PubMed         Abstract available

  48. MASEKO B, Bula A, Sasse S, Thom A, et al
    Opinions on integrating couple counselling and female sexual reproductive health services into Voluntary Medical Male Circumcision services in Lilongwe, Malawi.
    PLoS One. 2022;17:e0273627.
    PubMed         Abstract available

    Pol J Radiol

  49. GUI B, Russo L, Minordi L, Micco M, et al
    The role of apparent diffusion coefficient (ADC) in the evaluation of lymph node status in patients with locally advanced cervical cancer: our experience and a review.
    Pol J Radiol. 2022;87:e438-e447.
    PubMed         Abstract available

    Rev Invest Clin

  50. ZHANG L, Zhang Y, Zhou J, Wang Y, et al
    LncRNA NR2F1-AS1 Inhibits the Malignant Properties of Cervical Cancer Cells via Targeting miR-642a-3p/NR2F1 Axis.
    Rev Invest Clin. 2022;74:181-192.
    PubMed         Abstract available

    Taiwan J Obstet Gynecol

  51. YASUNAGA M, Yahata H, Okugawa K, Shimokawa M, et al
    Prognostic impact of adding bevacizumab to carboplatin and paclitaxel for recurrent, persistent, or metastatic cervical cancer.
    Taiwan J Obstet Gynecol. 2022;61:818-822.
    PubMed         Abstract available

    Transl Cancer Res

  52. SHAN L, Wang X, Li Y, Li L, et al
    Elevated expression of protein-L-isoaspartate O-methyltransferase-1 (PCMT1) in cervical cancer.
    Transl Cancer Res. 2022;11:2582-2590.
    PubMed         Abstract available


  53. PALMER M, Katanoda K, Saito E, Acuti Martellucci C, et al
    Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis.
    Vaccine. 2022 Sep 6. pii: S0264-410X(22)00950.
    PubMed         Abstract available

    Virol J

  54. LI X, Xiang F, Dai J, Zhang T, et al
    Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China.
    Virol J. 2022;19:146.
    PubMed         Abstract available

    Zhong Nan Da Xue Xue Bao Yi Xue Ban

  55. CHENG T, Zhang Z, Yang X, Lu S, et al
    Automatic delineation of organ at risk in cervical cancer radiotherapy based on ensemble learning.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022;47:1058-1064.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.